Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis (Q33246409)

24 July 2017

0 references

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis (English)

1 reference

24 July 2017

0 references

John P Cooke

4

0 references

Shelley R. Salpeter

series ordinal

2

object named as

Shelley R Salpeter

1 reference

24 July 2017

Jan T Kielstein

1

1 reference

24 July 2017

Stefanie M Bode-Boeger

series ordinal

3

1 reference

24 July 2017

Danilo Fliser

series ordinal

5

1 reference

24 July 2017

language of work or name

English

0 references

publication date

9 June 2006

1 reference

Nephrology Dialysis Transplantation

24 July 2017

published in

1 reference

24 July 2017

volume

21

1 reference

24 July 2017

issue

9

1 reference

24 July 2017

page(s)

2446-2451

1 reference

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetrical dimethylarginine: the Uber marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

State of the arg: protein methylation at arginine comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Creatinine clearance in renal disease. A reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Measurement of renal function in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Limitations of creatinine as a filtration marker in glomerulopathic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Novel Risk Markers and Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

Accumulation of symmetric dimethylarginine in hepatorenal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFL292

21 January 2018

Identifiers

DOI

10.1093/NDT/GFL292

1 reference

release_hzn54ogzunfc3bcqmf3oiqsbae

24 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hzn54ogzunfc3bcqmf3oiqsbae

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference